Brind.

Roche is named CEO of Analog Devices, and UBS questioned the company's performance.

2 reports, 1 independent Updated Aug 27

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Roche is named CEO of Analog Devices, and UBS questioned the company's performance.

Who's involved

What this event is mainly about

UBS Hoffmann-La Roche Analog Devices

Keep exploring

The entities involved

UBS
Swiss multinational investment bank and financial services company
- The Trump administration threatens tariffs on Switzerland, leading Switzerland to seek a new trade agreement with the US.Mon 00:13
- Following the acquisition of Credit Suisse, the Swiss parliament proposed new banking regulations for UBS.Sun 10:25
Hoffmann-La Roche
Swiss healthcare company
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
- Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
Analog Devices
American company
- Analog Devices is listed on the Nasdaq exchange.Mon 02:01
- Texas Instruments and Analog Devices are currently trading at high forward earnings multiples.Sun 18:26

Coverage

Newest first; wire copies grouped

Aug 27StockStoryAnalog Devices’s Q2 Earnings Call: Our Top 5 Analyst Questions Analog Devices delivered better-than-expected results for Q2, with management attributing the strong performance to robust demand across
Jul 1Unknown outlet